jobs.jnj.com/en/jobs/
Skip to content
✕
Internet Explorer is no longer supported by this website.
For optimal browsing we recommend using
Chrome
,
Firefox
or
Safari
.
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Menu
Search
Toggle Menu
Change Country
Our Stories
Latest News
Innovation
Caring & Giving
Personal Stories
Health & Wellness
Our Heritage
Our Company
About J&J
Our Credo
Our Leadership Team
Code of Business Conduct
Corporate Reports
Diversity, Equity & Inclusion
ESG Policies & Positions
Innovation at J&J
Digital Solutions
J&J Health and Wellness Solutions
Office of the Chief Medical Officer
Veterans, Military & Military Families
Products
MedTech
Pharmaceutical Products
Suppliers
Responsible Supply Base
Supplier-Enabled Innovation
Supplier Resources
Careers
Life at J&J
Diversity, Equity and Inclusion
Career Areas of Impact
Students
Re-Ignite Program
Contract & Freelance Partner Opportunities
Career Stories
Media Center
Investors
2023 Annual Meeting of Shareholders
Corporate Governance
Quarterly Results
SEC Filings
News Releases
Pharmaceutical Pipeline
2022 Janssen Transparency Report
2022 Health for Humanity Report
ESG Resources
Stock Information
Webcasts & Presentations
Investor Fact Sheet
Our Societal Impact
Global Community Impact
Global Public Health
Global Environmental Sustainability
Close Countries Menu
Explore more Johnson & Johnson sites:
China
France
Germany
India
Japan
Russia
Switzerland
German
English
French
United Kingdom
United States
Close Search Menu
Search input
Share
Latest News
Read the Story
"No One Would Believe Me When I Suspected I Had Lung Cancer"
"No One Would Believe Me When I Suspected I Had Lung Cancer"
More From Johnson & Johnson
Caring & Giving
How Johnson & Johnson Is Helping Build a Sense of Belonging By Investing in Student Nurses of Color
How Johnson & Johnson Is Helping Build a Sense of Belonging By Investing in Student Nurses of Color
ON NOW
What You Need to Know About Johnson & Johnson's 2023 Second-Quarter Earnings
Latest News
What You Need to Know About Johnson & Johnson's 2023 Second-Quarter Earnings
What You Need to Know About Johnson & Johnson's 2023 First-Quarter Earnings
ON NOW
15 Employee Benefits That Help Make Johnson & Johnson a Great Company
Innovation
15 Employee Benefits That Help Make Johnson & Johnson a Great Company
15 Employee Benefits That Help Make Johnson & Johnson a Great Company
ON NOW
Driving Diversity in Medical Illustration
Latest News
Driving Diversity in Medical Illustration
Driving Diversity in Medical Illustration
Ready the Story
ON NOW
5 Things We Now Know About Myasthenia Gravis
Health & Wellness
5 Things We Now Know About Myasthenia Gravis
5 Things We Now Know About Myasthenia Gravis
Read the Story
Latest Press Releases
Latest News
August 11, 2023
U.S. FDA Approves AKEEGA™ (Niraparib and Abiraterone Acetate), the First-And-Only Dual Action Tablet for the Treatment of Patients with BRCA-Positive Metastatic Castration-Resistant Prostate Cancer
Latest News
August 10, 2023
U.S. FDA Approves TALVEY™ (talquetamab-tgvs), a First-in-Class Bispecific Therapy for the Treatment of Patients with Heavily Pretreated Multiple Myeloma
Latest News
August 04, 2023
Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
See All Press Releases
Back to top
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue